CPT code 85230: Factor VII assay, proconvertin activity2026 Medicare lab fee · Clinical Laboratory Fee Schedule

Measures clotting factor VII activity in plasma, commonly during evaluation of a prolonged prothrombin time or suspected factor VII deficiency.

CMS CLFS 2026 Q4Effective Oct 1, 2026Same amount nationwide1.1K Medicare services in 2024

Medicare pays $17.90 for 85230 under the 2026 Clinical Laboratory Fee Schedule: one national amount, the same in every state and setting.

Medicare lab fee · CLFS 2026 Q4

National CLFS amount

$17.90

In effect since Jan 1, 2026. The same amount in every state, payment locality and setting.

Geographic adjustment
None
Office vs facility
Same
Since 2020
Unchanged
CMS updates
Quarterly

Medicare pays the lesser of the lab’s charge and this amount. Patients usually owe no Part B deductible or coinsurance for covered clinical lab tests.

On this page 8 sections
  1. Medicare lab fee
  2. What 85230 covers
  3. How it’s paid
  4. Amount history
  5. Similar tests
  6. Related codes
  7. Billing questions
  8. Sources

What 85230 covers

A factor VII activity assay measures the function of proconvertin, a clotting protein in the extrinsic pathway. Coagulation laboratories commonly perform a clot-based activity test using patient plasma and factor VII-deficient substrate plasma. Clinicians may order it to investigate an unexplained prolonged prothrombin time, evaluate suspected congenital factor VII deficiency, or assess an acquired reduction in factor VII activity.

Report this code for the factor VII assay performed; it represents a specific factor test rather than a multi-factor panel. Medicare pays the test only through the CLFS. The 2026 national CLFS amount is $17.90, unchanged since 2020; one amount applies across localities, without geographic or office-versus-facility adjustment. The test is excluded from the physician fee schedule, so its payment comes from the CLFS.

This summary was written with AI assistance from CMS Clinical Laboratory Fee Schedule data. Amounts on this page come directly from CMS files.

How Medicare pays 85230

Clinical lab tests aren’t priced like physician services. They’re paid from their own fee schedule, with its own rules. See the whole lab fee schedule.

One national amount

CMS sets a single Clinical Laboratory Fee Schedule amount for 85230. There’s no geographic (GPCI) adjustment, so it pays the same in every state and payment locality.

No office or facility rate

Lab tests aren’t built from relative value units, so there’s no office and facility split: the place of service doesn’t change the CLFS amount.

Updated every quarter

CMS republishes the CLFS each quarter. New tests, often proprietary laboratory analyses (PLA codes), join during the year; existing amounts are updated each January.

Excluded from the physician fee schedule

The physician fee schedule lists 85230 with status X (excluded by statute), so the test itself is paid only from the CLFS.

85230 on the lab fee schedule since 2020

85230 · CLFS 2026 Q4 (current)

$17.90

Unchanged since Jan 1, 2020

Amount in each year’s latest CLFS release · bars start at $0

27 quarterly CLFS releases on file, first CLFS 2020 Q1. A code missing from a quarter wasn’t on that release.

85230 compared with similar tests

85210Factor II assayProthrombin measurement$12.98
85210 evaluates factor II activity. This code evaluates factor VII activity; select according to the factor being tested.
85220Factor V assayActivity measurement$17.65
85220 evaluates factor V activity. Use this code when the assay measures factor VII instead.
85610Prothrombin timeRoutine coagulation test$4.29
85610 reports the prothrombin time screening test. This code reports a factor VII-specific activity assay, which may be part of a follow-up workup.

85230 billing questions

When should factor VII testing be chosen instead of a prothrombin time?

Prothrombin time is a screening test; factor VII testing evaluates the activity of that specific clotting factor. It may follow an abnormal prothrombin time when the clinical workup calls for a factor-specific result.

How is this code different from factor II testing?

This code is for factor VII activity. Use 85210 for a factor II assay; the codes identify different clotting factors.

Does this code include testing for other clotting factors?

No. It identifies factor VII testing, not assays for factors II, V, or X. Report other factor assays when they are performed and supported by the record.

How does Medicare pay for this test?

Medicare pays it through the CLFS, using one national amount across localities and settings. The test is excluded from the physician fee schedule.

Where this amount comes from

FeeBase reads lab amounts directly from the CMS Clinical Laboratory Fee Schedule file for the quarter: one row per code, with its payment indicator and national amount. Contractor-priced tests are labeled, never given a made-up amount. Amounts are Medicare payment limits, not a patient’s bill or a commercial rate.

CMS CLFS 2026 Q4 · effective Oct 1, 2026 through the day before Jan 1, 2027

Show the CMS file line behind this amount
CLFS row for 85230PUF_CLFS_CY2026_Q4V1.csv, line 1,551 (CLFS 2026 Q4)

Open CMS sourceHow we source rates

Did this answer your question about what Medicare pays for 85230?

Tell us what you were actually trying to work out. We’ll answer you directly, or build the page that does.

Fee sheets · Coming soon

Put 85230 and the rest of your codes on one sheet

Your codes at your locality, with payer contracts beside Medicare.

Join the waitlist